{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:53:13Z","timestamp":1789617193794,"version":"build-2803163510"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Research on low-dose-rate (LDR) brachytherapy for gynecological cancer primarily examines treatment toxicity while overlooking aspects such as sexual desire, arousal, orgasm, satisfaction, and overall quality of life. We assessed sexual function and quality of life in patients with cervical and endometrial cancer before and after LDR brachytherapy, identifying factors related to sexual dysfunction and good quality of life 3\u20136 months after brachytherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      We prospectively followed a cohort of patients with a histopathological diagnosis of cervical and endometrial cancer who were treated with LDR intracavitary brachytherapy (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f139). The SyDSF-AP, FACT-G, PHQ-9, and PHQ-15 scales were collected using a self-administered questionnaire before and 3\u20136 months after treatment. The analysis included estimating incidence rates and conducting a binary multiple logistic regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sexual dysfunction was observed in 14.4% of individuals, with 30% already affected at baseline. Higher education was associated with a decreased likelihood of developing or maintaining sexual dysfunction (OR, 0.10; 95% CI, 0.01\u20130.97). Physical wellbeing improved after treatment, with scores increasing from 69.3 to 78.7 (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001; effect size\u202f=\u202f0.34). The presence of moderate-to-severe somatic symptoms, major depression, and sexual dysfunction reduced the likelihood of starting or maintaining a good quality of life.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Over 10% of patients experienced sexual dysfunction, with physical wellbeing being the only area that showed improvement after treatment. Research in this area enhances awareness and understanding of how healthcare providers can better support sexual and health-related wellbeing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1584141","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:13:06Z","timestamp":1745799186000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Sexual dysfunction and quality of life in cervical and endometrial cancer patients before and after low-dose-rate brachytherapy: a cohort study"],"prefix":"10.3389","volume":"12","author":[{"given":"Celia B.","family":"Gonz\u00e1lez-Alcorta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina","family":"Alcorta-Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daneli","family":"Ruiz-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca Ang\u00e9lica","family":"Soto-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Alcorta-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzel Lidey","family":"Galaviz-Reynoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola A.","family":"L\u00f3pez-Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Francisco","family":"Gonz\u00e1lez-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Vidal-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"ref1","year":"2024"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3322\/caac.21578","article-title":"Brachytherapy: an overview for clinicians","volume":"69","author":"Chargari","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.brachy.2018.11.009","article-title":"Brachytherapy: a critical component of primary radiation therapy for cervical cancer","volume":"18","author":"Holschneider","year":"2019","journal-title":"Brachytherapy"},{"key":"ref4","year":"2024"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"7052","DOI":"10.3389\/fonc.2021.677052","article-title":"Analysis of applicator insertion related acute side effects for cervical Cancer treated with brachytherapy","volume":"11","author":"Chen","year":"2021","journal-title":"Front Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.brachy.2012.04.007","article-title":"Interstitial preoperative high-dose-rate brachytherapy for early stage cervical cancer: dose\u2013volume histogram parameters, pathologic response and early clinical outcome","volume":"12","author":"Hannoun-Levi","year":"2013","journal-title":"Brachytherapy"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11884-016-0354-7","article-title":"Incontinence, voiding dysfunction, and other urologic complications after radiotherapy for gynecologic malignancies","volume":"11","author":"Greear","year":"2016","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ygyno.2010.01.034","article-title":"Long-term cervical cancer survivors suffer from pelvic floor symptoms: a cross-sectional matched cohort study","volume":"117","author":"Hazewinkel","year":"2010","journal-title":"Gynecol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"813352","DOI":"10.3389\/fmed.2021.813352","article-title":"Sexual health dysfunction after radiotherapy for gynecological Cancer: role of physical rehabilitation including pelvic floor muscle training","volume":"8","author":"Barcellini","year":"2022","journal-title":"Front Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5114\/jcb.2018.79713","article-title":"Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results","volume":"10","author":"Delishaj","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3109\/0284186X.2014.1001036","article-title":"Reduced vaginal elasticity, reduced lubrication, and deep and superficial dyspareunia in irradiated gynecological cancer survivors","volume":"54","author":"Stinesen Kollberg","year":"2015","journal-title":"Acta Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5380\/ce.v27i0.86926","article-title":"Effects of brachytherapy on quality of life and functionality in the treatment of cervix cancer","volume":"27","author":"de Freitas","year":"2022","journal-title":"Cogitare Enferm"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ygyno.2011.11.030","article-title":"A systematic review of sexual concerns reported by gynecological cancer survivors","volume":"124","author":"Abbott-Anderson","year":"2012","journal-title":"Gynecol Oncol"},{"key":"ref14","year":"2024"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12094-008-0208-7","article-title":"Pulsed dose rate brachytherapy","volume":"10","author":"Polo","year":"2008","journal-title":"Clin Transl Oncol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.brachy.2018.12.009","article-title":"Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer","volume":"18","author":"Annede","year":"2019","journal-title":"Brachytherapy"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.brachy.2020.07.015","article-title":"Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives","volume":"19","author":"Abdel-Wahab","year":"2020","journal-title":"Brachytherapy"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.rpor.2020.06.002","article-title":"Radiation oncology in Mexico: current status according to Mexico\u2019s radiation oncology certification board","volume":"25","author":"Maldonado Magos","year":"2020","journal-title":"Rep Pract Oncol Radiother"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00404-016-4099-5","article-title":"Sexual function and quality of life in gynecological cancer pre- and post-short-term brachytherapy: a prospective study","volume":"294","author":"Zomkowski","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.ijrobp.2015.12.363","article-title":"Health-related quality of life in locally advanced cervical Cancer patients after definitive Chemoradiation therapy including image guided adaptive brachytherapy: an analysis from the EMBRACE study","volume":"94","author":"Kirchheiner","year":"2016","journal-title":"Int J Radiat Oncol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.5114\/jcb.2022.119198","article-title":"Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule","volume":"14","author":"Facondo","year":"2022","journal-title":"J Contemp Brachytherapy"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/0360-3016(94)90388-3","article-title":"Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma","volume":"29","author":"Haie-Meder","year":"1994","journal-title":"Int J Radiat Oncol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.5114\/jcb.2018.77953","article-title":"EROS study: evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis","volume":"10","author":"Autorino","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1590\/S0104-42302011000400019","article-title":"Adjuvant radiotherapy in early stage endometrial cancer","volume":"57","author":"Zuliani","year":"2011","journal-title":"Rev Assoc Med Bras"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1634\/theoncologist.2010-0326","article-title":"Low-dose-rate definitive brachytherapy for high-grade vaginal intraepithelial neoplasia","volume":"16","author":"Blanchard","year":"2011","journal-title":"Oncologist"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1138-3593(07)73836-4","article-title":"SyDSF-AP: un cuestionario de 21 \u00edtems para aproximarnos a la salud sexual y detectar las disfunciones sexuales femeninas en Atenci\u00f3n Primaria","volume":"33","author":"Casas Aranda","year":"2007","journal-title":"Med Fam Semergen"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The functional assessment of Cancer therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J Clin Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/1099-1611(200101\/02)10:1<88::AID-PON483>3.0.CO;2-S","article-title":"Evaluation of the functional assessment of Cancer therapy-general questionnaire (FACT-G) in a south American Spanish speaking population","volume":"10","author":"Dapueto","year":"2001","journal-title":"Psychooncology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/00006842-200203000-00008","article-title":"The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms","volume":"64","author":"Kroenke","year":"2002","journal-title":"Psychosom Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"ref31","first-page":"345","article-title":"Validation of the Spanish version of the PHQ-15 questionnaire for the evaluation of physical symptoms in patients with depression and\/or anxiety disorders: DEPRE-SOMA study","volume":"38","author":"Ros Montalb\u00e1n","year":"2010","journal-title":"Actas Esp Psiquiatr"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4067\/S0034-98872019000100053","article-title":"Propiedades psicom\u00e9tricas del PHQ-9 (Patient Health Questionnaire) en centros de atenci\u00f3n primaria de Chile","volume":"147","author":"Saldivia","year":"2019","journal-title":"Rev Med Chile"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00520-019-04872-4","article-title":"Screening for sexual health concerns in survivors of gynecological cancer","volume":"28","author":"Roberts","year":"2020","journal-title":"Support Care Cancer"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/ijgo.12623","article-title":"Psychosexual health in gynecologic cancer","volume":"143","author":"Boa","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/ijgc-2018-000096","article-title":"Approach to sexual dysfunction in women with cancer","volume":"29","author":"Del Pup","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1097\/IGC.0000000000000236","article-title":"Long-term sexual functioning in women after surgical treatment of cervical Cancer stages IA to IB: a prospective controlled study","volume":"24","author":"Aerts","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/jsm.12764","article-title":"Sexual functioning in women after surgical treatment for endometrial Cancer: a prospective controlled study","volume":"12","author":"Aerts","year":"2015","journal-title":"J Sex Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12978-022-01369-y","article-title":"What factors shape quality of life for women affected by gynaecological cancer in south, south east and east Asian countries? A critical review","volume":"19","author":"Spagnoletti","year":"2022","journal-title":"Reprod Health"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.7860\/JCDR\/2013\/6813.3822","article-title":"Female sexual dysfunction: prevalence and risk factors","volume":"7","author":"Jaafarpour","year":"2013","journal-title":"J Clin Diagnostic Res"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1111\/jsm.12508","article-title":"Sexual behavior and symptoms among reproductive age Chinese women in Hong Kong","volume":"11","author":"Lo","year":"2014","journal-title":"J Sex Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"11993","DOI":"10.1038\/s41598-018-30506-6","article-title":"Impact of cervical cancer on quality of life of women in Hubei, China","volume":"8","author":"Thapa","year":"2018","journal-title":"Sci Rep"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.currproblcancer.2013.10.009","article-title":"Management of sexual problems in cancer patients and survivors","volume":"37","author":"Sanchez Varela","year":"2013","journal-title":"Curr Probl Cancer"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1584141\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:13:08Z","timestamp":1745799188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1584141\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":42,"alternative-id":["10.3389\/fmed.2025.1584141"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1584141","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"article-number":"1584141"}}